Last year, it issued a compulsory licence for Nexavar, a drug that treats kidney and liver cancer and is patented by pharmaceutical giant Bayer. The compulsory licence overrides Bayer’s exclusive right to make and sell the drug and allows it to be manufactured at a lower cost. Read more »